Pharmadrug (TSE:PHRX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
PharmaDrug Inc. has announced its subsidiary, SecureDose, has signed a Letter of Intent with a Canadian licensed dealer to manufacture and distribute biosynthetic pharmaceutical grade cocaine, aiming to contribute to harm reduction through safe supply programs. The company is advancing towards a full agreement post technology transfer and commercial-scale process application, with potential global distribution and revenue opportunities.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.
